US Broker Ratings

BeOne Medicines Ltd. (ONC) Stock Analysis: Exploring a 12% Upside Potential in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Swiss-based oncology powerhouse, is capturing the attention of investors with its promising pipeline and an impressive 12.36% upside potential. With a market cap of $34.07..

Lantheus Holdings (LNTH) Stock Analysis: A Potential 82.83% Upside Amid Healthcare Innovations

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, is capturing the attention of individual investors. With a..

Tenet Healthcare Corporation (THC) Stock Analysis: Navigating a 6.72% Upside in a Competitive Healthcare Market

Tenet Healthcare Corporation (NYSE: THC), a significant player in the U.S. healthcare landscape, provides a compelling investment opportunity for those eyeing the medical care facilities sector. Despite recent challenges reflected..

Avantor, Inc. (AVTR) Stock Analysis: Investor Outlook with a 27.34% Potential Upside

Avantor, Inc. (NYSE: AVTR) has emerged as a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $9.06 billion, Avantor..

Glaukos Corporation (GKOS) Investor Outlook: Analyzing a 25% Upside Potential Amidst Revenue Growth

Glaukos Corporation (NYSE: GKOS), a key player in the healthcare sector, primarily focuses on innovative solutions within the medical devices industry. With a market capitalization of $5.58 billion, Glaukos has..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Valuation and Growth in a Dynamic Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the medical distribution industry based in the United States, is a key supplier of healthcare products and services to dental and..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 75% Revenue Growth in the Healthcare Sector

Tempus AI, Inc. (TEM) is making waves in the healthcare technology sector, and for good reason. With a remarkable 75.40% revenue growth, the company is positioned as a noteworthy player..

Option Care Health, Inc. (OPCH): Investor Outlook with a 30.79% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a leader in home and alternate site infusion services, is making waves in the healthcare sector. As the company continues to grow, investors are..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Navigating the 8.71% Dividend Yield Amidst Market Challenges

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a significant player in the healthcare sector, operating through a diverse range of services from retail pharmacy to international health and wellness..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Analyzing the 67% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, offers a compelling opportunity for investors with a reported potential upside of 67.22%. Specializing in the development of..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 38.62% Potential Upside Amidst Biotech Innovations

For investors with a keen eye on the biotechnology sector, Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) presents an intriguing opportunity. With a market capitalization of $6.65 billion, Ionis stands as a..

Roivant Sciences Ltd. (ROIV) Stock Report: Analysts See 46% Upside as Biotech Innovator Advances Pipeline

Roivant Sciences Ltd. (NASDAQ: ROIV) has captured the attention of investors with its promising pipeline of biopharmaceutical innovations. Based in London, this healthcare juggernaut operates within the biotechnology industry, focusing..

Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 21.79% Upside Potential

Becton, Dickinson and Company (NYSE: BDX) stands as a titan in the healthcare sector, with a robust market capitalization of $51.26 billion. Operating within the medical instruments and supplies industry,..

Qiagen N.V. (QGEN) Investor Outlook: Navigating Diagnostics Growth with a 3.66% Upside Potential

Investors eyeing opportunities in the healthcare sector might find Qiagen N.V. (NYSE: QGEN) an intriguing proposition, as the Dutch diagnostics and research company continues to leverage its robust portfolio of..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unpacking a Promising 30.75% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI) is a key player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in South Jordan, Utah, the company has..

Mettler-Toledo International (MTD) Stock Analysis: Navigating a 4.90% Potential Upside in the Healthcare Sector

Mettler-Toledo International Inc. (NYSE: MTD), a titan in the diagnostics and research industry, stands at the intersection of innovation and precision. With a market capitalization of $24.83 billion, this Columbus,..

Investor Outlook: Koninklijke Philips N.V. (PHG) Boasts 29% Potential Upside Amid Healthcare Sector Challenges

Koninklijke Philips N.V. (PHG), a stalwart in the healthcare sector specializing in medical devices, presents an intriguing case for investors with a 29.13% potential upside according to analyst targets. Despite..

DexCom, Inc. (DXCM) Stock Analysis: Unlocking a 17.52% Upside in the Healthcare Sector

DexCom, Inc. (DXCM), a stalwart in the medical devices industry, presents an intriguing opportunity for investors keen on the healthcare sector. With a market capitalization of $32.89 billion, DexCom specializes..

Pfizer Inc. (PFE) Stock Analysis: A 7.10% Dividend Yield with Nearly 20% Upside Potential

Pfizer Inc. (NYSE: PFE), a prominent player in the healthcare sector, has long been a cornerstone of the pharmaceutical industry. With a market capitalization of $139.12 billion, Pfizer’s influence stretches..

Waystar Holding Corp. (WAY) Stock Analysis: Unpacking a 31.18% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY) stands out in the healthcare sector with its innovative cloud-based software solutions that streamline healthcare payments. With a market capitalization of $6.35 billion, Waystar is..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds